Pioneer Psychiatrist Changed Mental Health for Kids

Dr. Judith L. Rapoport, a distinguished child psychiatrist, died on March 7 in Washington, D.C., at the age of 92. She was widely recognized for her impactful book, "The Boy Who Couldn't Stop Washing," published in 1989. This best-selling work brought significant public attention to obsessive-compulsive disorder (OCD).

Her research fundamentally shifted the understanding of OCD, demonstrating it has a neurological basis rather than stemming from emotional traumas. This contrasted with earlier psychiatric beliefs.

Rapoport's work also clarified that OCD was more common than previously thought, affecting 1 to 3 percent of the population. She further showed its biological origins and oversaw drug trials that led to the FDA's approval of the first OCD medication, Anafranil.

For 33 years, from 1984 to 2017, she served as chief of the child psychiatry branch at the National Institute of Mental Health (NIMH). Her leadership fostered a paradigm shift in child psychiatry, moving away from Freudian models towards biological and empirical research.

Beyond OCD, Dr. Rapoport also led influential studies on ADHD and childhood-onset schizophrenia. Her research on schizophrenia highlighted it as a progressive brain disorder, and she identified effective antipsychotic medications like clozapine and olanzapine. Her findings also challenged existing beliefs about stimulant medications in hyperactive children.

Born Judith Helen Livant on July 12, 1933, in Manhattan, she pursued her education at Swarthmore College and Harvard Medical School. After her training, she dedicated her career to advancing child mental health research and treatment, leaving a lasting legacy in the field.